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INTRODUCTION
End-of-life care, physician-assisted suicide, and decision-making
capacity have garnered increased attention as of late. The United
States Supreme Court recognized the import of such controversial
and compelling issues when it considered the question of the constitu-
tionality of physician-assisted suicide in June, 1997.1 In Washington v.
Glucksberg,2 the Court determined that, contrary to a finding by the
Ninth Circuit Court of Appeals,3 the right to physician assistance in
suicide was not one inherent to all Americans under the Fourteenth
Amendment's Due Process Clause.4 The Court similarly rejected the
Equal Protection argument that prevailed in the Second Circuit' and
reaffirmed that the distinction between forgoing life-sustaining treat-
ment and obtaining physician assistance in suicide is a valid one.6 In a
unanimous decision, the U.S. Supreme Court sent the question of as-
sisted suicide to state legislatures, simultaneously igniting a debate not
only in state congressional offices but also in hospital ethics commit-
tees, classrooms, newspaper editorial pages, and workplaces across the
country.
The Supreme Court's ruling notwithstanding, almost two-thirds
of respondents in most polls consistently seem to want a suicide op-
tion.7 These high numbers signify a clear rejection of the status quo.
Those on both sides of the physician-assisted suicide debate find some
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1. See Washington v. Glucksberg, 117 S. Ct. 2258 (1997); Vacco v. Quill, 117 S. Ct.
2293 (1997).
2. 117 S. Ct. 2258.
3. See Compassion in Dying v. Washington, 79 F.3d 790, 793-94 (9th Cir. 1996).
4. See Glucksberg, 117 S. Ct. at 2262.
5. See Quill v.Vacco, 80 F.3d 716, 731 (2d Cir. 1996).
6. See Vacco, 117 S. Ct. at 2297-98.
7. See John La Puma, Physician-Assisted Suicide, Managed Care: Unhappy Bedfellows, a
Match Made in Hell; MANAGED CARE, Aug. 1997, 125, 125; Robert J. Blendon et al., Should
Physicians Aid Their Patients in Dying?: The Public Perspective, 267 JAMA 2658, 2659 (1992).
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commonality in the recognition that requests for assistance in death
are usually a result of deficiencies in the health care system.' Our
health care system's ability to provide technological responses to ill-
ness and the often aggressive care people receive at the end of life
leave many people "fearful that the combination of old age and mod-
ern medicine will inflict on them a dying that is more protracted and,
in some ways, more difficult than it would have been a few decades
ago."9 Problems in end-of-life care are increasingly well documented,
ranging from undertreated pain to unwanted or futile treatments to
prolong life.1° Unfortunately, much of the public sees these as inevi-
table impositions and technological assaults - hence the public's in-
terest in the assisted suicide debate."
Good care of the dying calls for interdisciplinary care teams, con-
tinuity and coordination of care, integration of diverse services deliv-
ered across a variety of settings and financing arrangements, and
changes in the orientation and culture of providers and public alike;
not yet achieved under our current health care system. This paper
will examine some of the changes in our social and medical circum-
stances which have triggered the question of the individual's right to
physician-assisted suicide and provides a programmatic alternative for
ensuring that more of us can be comfortable and confident as we face
the ends of our lives.
Specifically, Part I will describe current end-of-life care options.
Part II will describe Medicaring projects which we argue would provide
an array of services appropriately tailored to persons with serious
chronic illnesses facing the ends of their lives. Finally, we conclude
that such projects would provide such care without a parallel increase
in costs.
I. CURRENT END-OF-LIFE CARE OPrIONS
Advances in health care and improvements in public health have
enabled most Americans to live longer and to survive many life-threat-
ening events such as premature birth, heart attacks, and traumatic in-
jury - major killers just a few decades ago. 2 Americans can typically
8. See COMMITTEE ON CARE AT THE END OF LIFE, INSTITUTE OF MEDICINE, APPROACHING
DEATH: IMPROVING CARE AT THE END OF LIFE 15-16 (Marilyn J. Field & Christine K Cassel
eds., 1997) (explaining the far-reaching recognition of the advent of institutionalized
death) [hereinafter IMPROVING CARE AT THE END OF LIFE].
9. Id at 14.
10. See id.
11. See id. at 14-15.
12. See id. at 14.
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now expect to live well into their eighth decade (median life expec-
tancy has reached 79 years of age for women and 73 years of age for
men). 3 In 1900, there were just three million elderly persons (those
65 years or older), comprising just 4.1% of the population."4 By 1994,
there were 33 million elderly (one in every eight Americans) - an
eleven-fold increase. Those 75 to 84 years of age increased from just
1% of the population to almost 7%, a seven-fold increase. The very
old (those over age 85) constitute the fastest growing segment of the
entire population, rising 28% between 1990 and 1994.15
One unanticipated consequence of larger numbers of persons liv-
ing into very old age has been the emergence of long-term, chronic
diseases as the major pathway to disability and death.' 6 Until the early
part of this century, death was "sudden" and could occur at any age,
usually from acute infectious diseases (particularly influenza, tubercu-
losis, and diphtheria), accidents, and complications of childbirth.' 7
The average age of death in 1900 was approximately 50 years of age,
whereas it is approximately 77 years of age today.'" People over the
age of 65 now account for 13% of the population and over 70% of all
deaths. In addition, the causes of death have changed. In an exami-
nation of 1993 Medicare claims data, Hogan found that over 80% of
all decedents had one of five kinds of illnesses in the year before
death: heart failure, chronic obstructive pulmonary disease, cancer,
stroke, or dementia.' 9 These illnesses disproportionately affect older
people2" and ordinarily occasion a prolonged course of increasing dis-
ability and illness prior to death. In 1994, nearly 40% of the elderly
13. See BUREAU OF THE CENSUS, U.S. DEP'T OF COMMERCE, STATISTICAL ABSTRACT OF THE
UNITED STATES 1996 88-89 (116th ed. 1996) [hereinafter STATISTICAL ABSTRACT]; Harry M.
Rosenberg et al., Births and Deaths: United States, 1995, 45 MONTHLY VITAL STATISTICS REP.,
Oct. 4, 1996, at 4.
14. See Charles F. Longino,Jr., Pressure from Our Aging Population Will Broaden Our Under-
standing of Medicine, 72 ACAD. MED. 841, 842 (1997).
15. See Frank B. Hobbes, The Elderly Population (visited Feb. 24, 1999) <http://
www.census.gov/population/www/pop-profile/elderpop.html>.
16. See IMPROVING CARE AT THE END OF LIFE, supra note 8, at 14.
17. SeeJudith M. Stillion, Death in the Lives of Adults: Responding to the Tolling of the Bell, in
DYING: FACING THE FACTS 303, 304-05 (Hannelore Wass & Robert A. Neimeyer eds., 3d ed.
1995) [hereinafter DYING: FACING THE FACTS].
18. See STATISTICAL ABSTRACT, supra note 13, at 88-89; Robert Fulton & Julie Fulton, A
Psychosocial Aspect of Terminal Care: Anticipatory Grief 2 OMEGA 91 (1971).
19. Interview with Christopher Hogan, Vice President, CHPS Consulting, in Washing-
ton, D.C. (July 1997).
20. See IMPROVING CARE AT THE END OF LIFE, supra note 8, at 37.
[VOL. 2:268
MEDICARING: QuALry END-oF-LiE CARE
population not living in institutions (12 million persons) were limited
in activities of daily living by chronic conditions.21
Dying from chronic illnesses is very costly. Most beneficiaries in
any one year have very small expenses, and a few have very large ones.
In fact, most of Medicare dollars in any one year are spent on less than
one-fifth of the beneficiaries. About 28% of Medicare funds are now
spent on care in the last year of life,2 2 which is geared toward expen-
sive, high-technology interventions and "rescue" care. Of the funds
Medicare spends on patients in their last year, about 40% is spent on
care given in the last 30 days of life and 50% for care in the last 60
days.
23
Although Medicare costs overall increased nearly four-fold from
1976 to 1988, Lubitz and Riley showed that dying patients utilized the
same relative share of Medicare expenses and patterns of expenses.24
Using data from 1979, Riley, Lubitz, and colleagues found substantial
variation among diseases in costs at the end of life.25 In their 1993
study, Riley and Lubitz examined the pattern of expenditures over
time for the same causes of death.2 6 These studies provide evidence
that dying from certain chronic illnesses is disproportionately expen-
sive over a long period.
Our cultural conception of dying is built upon our experience
with cancer. Most patients with solid tissue cancers (e.g., lung, gastro-
intestinal, renal) have a long period of functional stability despite pro-
gressive illness and a relatively predictable, brief final course of
decline, or terminal phase, 27 usually lasting less than six weeks. The
referral to hospice, when it occurs, happens after the start of a failing
phase that is clearly marked. This failing phase, usually one month
21. See CHRONIC CARE IN AMERICA: A 21- CENTURY CHALLENGE, 27 (Robert Wood John-
son Foundation ed. 1996).
22. See Muriel Gillick, The High Costs of Dying: A Way Out, 154 ARCHIVES OF INTERNAL
MED. 2134, 2134 (1994); see also Nelda McCall, Utilization and Costs of Medicare Services by
Beneficiaries in Their Last Year of Life, 22 MED. CARE 329, 330 (1984) (explaining a pattern of
high medical care expenditures in the last year of life); William D. Spector & Vincent Mor,
Utilization and Charges for Terminal Cancer Patients in Rhode Island, 21 INQUIRY 328 (1984)
(explaining a study showing that medical care costs stem mainly from the final months of
life, and are dominated by hospital charges).
23. See Gillick, supra note 22, at 2134.
24. SeeJames D. Lubitz & Gerald F. Riley, Trends in Medicare Payments in the Last Year of
Life, 328 NEw ENG. J. MED. 1092, 1094 (1993).
25. See Gerald Riley et al., The Use and Costs of Medicare Services by Cause of Death, 24
INQUIRY 233, 237 (1987).
26. See Lubitz & Riley, supra note 24, at 1092.
27. See IMPROVING CARE AT THE END OF LIFE, supra note 8, at 28-29.
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ahead of death, is found in all countries with hospice services. 28 Thus,
in the cancer paradigm, the disease prompts the "transition from cure
to comfort care," at a time when the patient is clearly failing.
In contrast, chronic illnesses, such as congestive heart failure
(CHF) or chronic obstructive pulmonary disease (COPD), do not fit
the course of most cancer deaths.29 Such diseases, even at the ad-
vanced stages, produce trajectories that usually have no identifiable
"failing" phase and have no clear physiological events which would
lead doctors (or family members) to label such a patient as "dying,"
even when he or she is extremely disabled. (See Figure 1).
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Chronic illnesses have a gradual onset of daily symptoms, unfold
over a long period of time, and often do not have a single unambigu-
ous cause.3" Frequently, they have multiple and shifting responses to
treatments, produce trajectories of illness that defy prediction, and
the costs of their care are high. For example, when CHF patients are
not experiencing an exacerbation of their disease, they say they are
fine and feel well. 32 They have adapted to activity and diet restrictions
and do not perceive their limitations as active illness. Death from
28. Interview with Vincent Mor, Director, Center for Gerontology and Health Care
Resources, Brown Univ., in Washington, D.C. (June 1998).
29. See THE CENTER TO IMPROVE CARE OF THE DYING, GEORGE WASHINGTON UNIVERSITY
MEDICAL CENTER, SECOND ANNUAL ACTIVITIES REPORT 15 (1997); see also IMPROVING CARE AT
THE END OF LIFE, supra note 8, at 29 (explaining sudden death from an unexpected cause).
30. See Andrew A. Skolnick, MediCaring Project to Demonstrate and Evaluate Innovative End-
of-Life Program for Chronically 111 279 JAMA 1511, 1511 (1998) (depicting figure by Joanne
Lynn & Anne M. Wilkinson).
31. See Longino, supra note 14, at 842.
32. SeeJoanne Lynn et al., Defining the "Terminally Ill:" Insights from SUPPORT, 35 DUQ.
L. REV. 311, 329-30 (1996) (hereinafter Defining the "Terminally Ill"] (explaining the unpre-
dictability of death from CHF).
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CHF occurs mostly from heart attacks, strokes, arrhythmias, or infec-
tions, which are quite unpredictable. Thus, death will almost always
seem to be "sudden" in these patients.
The inherent unpredictability of this more common course at the
end of life is illuminated by a "prognoses on the days before death"
analysis from the SUPPORT study. (See Figure 2)." SUPPORT, the
Study to Understand Prognosis and Preferences for Outcomes and
Risks of Treatments, collected data on 9,105 very sick hospitalized pa-
tients, identified problems in their care, and tried and failed to cor-
rect these problems.3 4 Data collected in the SUPPORT studywas used
to generate multivariate estimates of survival prognosis." The rela-
tionship of median estimates to time of death were examined for dif-
ferent diseases and for intensive care unit (ICU) settings of care. 6 All
patients, and especially CHF patients, had substantial odds to live
much longer than would have been expected by care providers, right
up to the day before death.3 7 Overall, SUPPORT patients were found
to have a median 51% chance of survival for two months just one week
ahead of death.3 " Median prognoses varied substantially among dis-
eases: lung cancer patients had a median prognosis of 17% to live two
months on the day before death and 50% chance just one week
before death.3 9 Those with CHF had a median prognosis of over 60%
to live two months4 ° and over 40% to live for six months on the day
before death. It is unlikely that physicians, patients, or their loved
ones would recognize that death is near with prognoses that so
strongly suggest hope. The median patient dying in SUPPORT still
had a very good chance to survive for two months, or to leave the
hospital, even on the day before death - few would describe these
patients as "dying."
33. See Alfred F. Connors, Jr. et al., A Controlled Tial to Improve Care for Seriously Ill Hospi-
talized Patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treat-
ments (SUPPORT), 274 JAMA 1591 (1995).
34. See id. at 1591. The SUPPORT study aimed to improve end-of-life decision making
and reduce the frequency of a mechanically supported, painful, and prolonged process of
dying. See id Patients used in the study included a total of 9105 adults hospitalized in one
of five teaching hospitals in the U.S. with one or more of nine life-threatening diagnoses -
overall six-month mortality rate of 47%. See id. The study entailed a two-year prospective
observational study with 4301 patients followed by a two-year controlled clinical trial with
4804 patients and their physicians randomized by specialty group to the intervention
group (n=2652) or control group (n=2152). See id.
35. See Defining the "Terminally Ill," supra note 32, at 314.
36. See id. at 324-27.
37. See id.
38. See id. at 326.
39. See id. at 329.
40. See id. at 327.
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These data illuminate the current limits of our ability to predict
death, even when it is very close. Despite the ability of prognostic
models to estimate survival for groups of patients, these data show that
there is wide variability in the actual survival time of individual pa-
tients. Many sick persons, their families, and their physicians would
see these patients as in need of treatment to improve their chances.
Thus, at least for advanced chronic illness, one cannot always rely
upon there being a period of time in which dying is evidently near or
which is long enough to allow those involved to "plan for the death."
Consequently, for those with advanced chronic illness, it may be most
useful to develop parallel streams of plans: one which facilitates dis-
cussion about death and optimal support of the patient and family
through to death and for the family afterward and a second set of
plans which provides maximal effort to restore physiologic balance.4 1
Unfortunately, few medical systems accomplish this "combined"
management approach to seriously ill patients; i.e., seeking survival
while acknowledging and planning for the likelihood of death. With
progress in medical technology has come increased specialization in
health care delivery. Death, along with the rest of health care, has
41. SeeJoanne Lynn et al., Prognoses of Seriously Ill Hospitalized Patients on the Days Before
Death: Implications for Patient Care and Public Policy, 5 NEw HORIZONS 56, 61 (1997).
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become increasingly institutionalized and "medicalized."42 Over the
last hundred years, death has been moved from the home and into
institutions. In 1949, national statistics showed that 50% of all deaths
occurred in institutions (39.5% in general hospitals and the rest in
psychiatric and other kinds of hospitals and nursing homes) ;43 by
1980, 74% of all deaths occurred in institutions (60.5% in hospitals
and 13.5% in other institutions).44
The extension of life expectancy and increasing medicalization of
all aspects of life, including death, has presented the medical commu-
nity with a challenge. The U.S. health care system has historically fo-
cused on the treatment of acute diseases, accidents, and rescue care,
with cure as the goal. However, this type of care system is sadly mis-
matched with the needs of persons who will steadily deteriorate with a
chronic illness to death. Sometimes, invasive attempts to prolong life
are less preferable than supportive and palliative care might be. Find-
ing the right combination for each patient is extremely important but
also difficult to do.
Data collected in the SUPPORT study showed that half of those
conscious near death were reported by family members to be in mod-
erate to severe pain most of the time.45 The median death in this
study followed more than a week in an ICU.46 Patients and their phy-
sicians did not routinely make plans for end-of-life care or even con-
verse about the overall course of the disease or how to manage
predictable problems along the way.47 An order to forgo resuscitation
was written, on average, only two days prior to death.48
Moreover, individuals living with advanced and progressive
chronic illness face a disastrously fragmented and disorganized health
care system. Health care is organized by site of care (hospital, nursing
home, clinic, etc.); treated according to disease (renal failure, heart
attack, etc.); and rates of payment based on intervention (cardio-tho-
racic surgery, diagnostic radiology, etc.)." However, this is not how
42. See generally Jeanne Quint Benoliel & Lesley F. Degner, Institutional Dying: A Conver-
gence of Cultural Values, Technology, and Social Organization, in DYING: FACING THE FACTS, supra
note 17, at 117.
43. See Monroe Lerner, When, Why and Where People Die, in THE DYING PATIENT 21
(Orville G. Brim, Jr. et al., eds. 1970).
44. See Dwight B. Brock & Daniel J. Foley, Demography andEpidemiology of Dying in the
U.S. with Emphasis on Deaths of Older Persons, 13 HOSPICEJ. 49, 53 (1998).
45. See Connors et al., supra note 33, at 1594.
46. See id.
47. See id. at 1591.
48. See id.
49. See Mark S. Lachs & Hirsch S. Ruchlin, Is Managed Care Good or Bad for Geriatric
Medicine?, 45J. AM. GERIATRICS Soc'v 1123, 1123-27 (1997); see generally R. Sean Morrison &
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dying patients experience illness. Instead, advanced chronic illness is
more often progressive, cumulative, multiple, and fatal.5" These pa-
tients are ill-served by a system in which physician encounters are
brief, technology is emphasized, care is uncoordinated and provided
by a multitude of providers, hospitalizations and procedures cause ia-
trogenic illnesses, and the financial incentives of the reimbursement
system favor the continued utilization of high technology procedures
over relatively simple, and perhaps more appropriate, palliative meas-
ures." All of these factors lead to inefficiencies in service delivery,
lack of continuity, and cost-increasing incentives to over-treat and
over-serve patients. 52 Moreover, the current fee-for-service system,
which covers 90% of the elderly Medicare population, does not pay
for the kind of care that could ensure better coordination of services
and prevention of crises; nor does it pay for multidisciplinary teams of
providers who could provide continuity of care across health care de-
livery sites and over a long period of time.53
The integration of delivery and financing of healthcare under
managed care arrangements represents a significant change in the
health care delivery landscape. The older, not-for-profit managed
care systems have been shown to create incentives for prevention, the
reduction of service use when possible and cost containment without
adverse effects on health outcomes.54 However, the more recent ad-
vent of for-profit managed care is more often than not viewed as "care
denying." In theory, these managed care arrangements can allow the
flexibility of funding, personnel, physical plant, location, and ability to
Diane E. Meier, Managed Care at the End of Life, 10 TRENDS HEALTH CARE L. & ETHICS 91
(1995).
50. See generally Lachs & Ruchlin, supra note 49.
51. See id.
52. See id.
53. See id.
54. See, e.g., Nathan R. Every et al., Resource Utilization in Treatment of Acute Myocardial
Infarction: StaffModel Health Maintenance Organization Versus Fee-for-Service Hospitals, 26 J. AM.
C. CARDIOL. 401 (1995) (concluding that physicians in staff-model health maintenance
organization (HMO) hospitals use fewer invasive procedures and longer durations of stay
for treatment of patients with acute myocardial infarction than physicians in fee-for-service
hospitals); Sheldon Greenfield et al., Variations in Resource Utilization Among Medical Special-
ties and Systems of Care: Results from the Medical Outcomes Study, 267JAMA 1624 (1992) (exam-
ining whether specialty and system of care exert independent effects on resource
utilization); Willard G. Manning, A Controlled Trial of the Effect of a Prepaid Group Practice on
Use of Services, 310 NEw ENG. J. MED. 1505 (1984) (finding hospitalization rates under an
HMO-type system to be 40% lower than those under a fee-for-service system); see also Shel-
don M. Retchin & Jeanette Preston, Effects of Cost Containment on the Care of Elderly Diabetics,
151 ARCHIVES OF INTERNAL MED. 2244 (1991) (concluding, in study of diabetic HMO en-
rollees, that the quality of diabetic care under HMOs was similar to that under a fee-for-
service system).
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track patients necessary for more systematic planning and delivery of
services, especially for geriatric patients and those with advanced
chronic illnesses. Nevertheless, the principles of "gatekeeping," the
potential for the reduction of beneficial, as well as unnecessary tests
and procedures, and the pressures for cost containment (i.e., short
lengths of stay, etc.) raise concerns about the quality of care that en-
rollees may receive.
Finally, the existing reimbursement system, whether fee-for-ser-
vice or managed care, has provided little incentive for providers to
focus on elements of a good end-of-life care delivery model, such as
functional status, continuity, or prevention. Pain management is rou-
tinely ignored and providers are rarely continuous across time or sites.
End-of-life care often falls to physician specialists focused on rescue
(e.g., oncologists, cardiologists) when multi-disciplinary teams atten-
tive to nursing and social issues could provide more effective and
more reliable supportive care. All the evidence suggests that patients
and their families have little ability to reshape care to better meet
their needs compared with the influence of provider supply and estab-
lished care patterns.55
For persons with less serious or more curable illnesses, these
shortcomings of patient care might be considered to be minor annoy-
ances (e.g., the inconvenient location of care services) or merely
amenities (e.g., spiritual counseling, dignity of the person, respect for
patient's wishes). In the context of a fatal illness, however, these is-
sues acquire paramount importance. Yet, in the current system of
care, we do not hold anyone accountable for these shortcomings nor
are they measured or compared.56 Virtually all current efforts to im-
prove care for those with chronic illness focus on the early diagnosis
and management of the disease (i.e., disease management programs)
and tend to ignore the fact that care needs are shaped by the eventual
outcome of the illness. The dying have different care needs than those
who are sick but stable or likely to improve.
The only program for specialized end-of-life care is hospice. Hos-
pice has shown that care can effectively and efficiently focus on just
the final phase of life. Hospice utilizes less costly sites of care and
providers from multiple disciplines working in close teams; attends to
specific personal, spiritual, and clinical needs; and delivers appropri-
ate medical, nursing, and social supports. Hospice acts both as an
55. See Connors, supra note 33, at 1596.
56. See Alzheimer's Ass'n et al., Measuring Quality of Care at the End of Life: A Statement of
Principles, 45J. AM. GERIATRICS Soc'y 526, 526-27 (1997).
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insurer and as a provider in that it delivers almost all needed care for
a global payment (mostly a set rate per day at home, with other rates
for in-patient or continuous nursing attendance). Hospice has set the
standard for good end-of-life care through the use of interdisciplinary
teams that coordinate care and manage costs, a focus on the patient
and family as the unit of care, and reliable and effective service deliv-
ery (e.g., 24 hour on-call availability of providers) and state of the art
pain and symptom management. The benefit is quite flexible com-
pared to traditional fee-for-service. The average per diem was $96 per
day in routine home care in 1996; and home care accounts for nearly
90% of all days of care.57 The program has enjoyed wide approval.58
By electing hospice (either through Medicare or private insur-
ance), patients agree to forgo "life prolonging" interventions and, in-
stead, receive comprehensive medical and support services not
otherwise available under Medicare or their insurance.59 A study ex-
amining the effects of hospice on Medicare Part A expenditures dur-
ing the first three years of the program compared treatment costs
between hospice beneficiaries and non-hospice patients who had a di-
agnosis of malignant cancer during their last seven months of life.60
The study findings indicated that Medicare saved $1.26 for every dol-
lar spent on Part A expenditures. 61 A national evaluation of hospice
found that hospice users, compared to weakly matched non-users,
were less costly.62 For patients in home-based hospice, costs were
$2,221 lower than for "conventional-care patients."6 Care for hospi-
tal-based hospice patients was less costly, but only in their last month
of life. 64 However, the final savings over the last year of life totaled
$585.65 A follow-up study found that cancer patients who used hos-
57. See General Information: Hospice Fact Sheet (visited Jan 21, 1999) <http://
www.nho.org/facts.htm>.
58. See, e.g., Charles H. Brooks, Cost Differences Between Hospice and Nonhospice Care: A
Comparison of Insurer Payments and Provider Charges, 12 EVALUATION & HEALTH PROFS. 159
(1989) (study finding hospice home care less costly than non-hospice care); Charles H.
Brooks & Kathleen Smyth-Strauch, Hospice Home Care Cost Savings to Third-Party Insurers, 22
MED. CARE 691 (1984) (same); CHRIS PERRONE ET AL., AN ANALYSIS OF THE COST SAVINGS OF
THE MEDICARE HOSPICE BENEFIT (1995) (same); see also VINCENT MOR ET AL. EDS., THE Hos-
PICE EXPERIMENT (1988) (explaining the results of the National Hospice Study).
59. See 42 C.F.R. §418.24(b) (3) (1998) (outlining procedure for determining Medicare
beneficiary hospice eligibility).
60. David Kidder, The Effects of Hospice Coverage on Medicare Expenditures, 27 HEALTH
SERV. RES. 195, 207 (1992).
61. See id.
62. See THE HOSPICE EXPERIMENT, supra note 58, at 66.
63. See id.
64. See id.
65. See id.
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pice cost Medicare, on average, $2,737 less than unmatched non-hos-
pice users." But, the apparent cost advantage is somewhat unreliable
given the lack of randomization in these studies.
Despite its advantages for patients, Medicare's various restrictions
shape and define hospice. The hospice benefit is limited to people
who have a "terminal illness with a life expectancy of six months or
less."67 The relatively predictable, brief final course of cancer is well
suited to the prognostic limit and hospice model of care. However,
individuals dying with diseases other than cancer generally do not
have access to hospice care, mostly because their illnesses do not have
clinically evident phases of overt decline at the end-of-life. (See Figure
3). In addition, the requirement that 80% of care be at home68 often
makes hospice care unavailable for those without family or others who
can assist them with medications, hygiene, nutrition, and other per-
sonal care services. Thus, hospice ends up serving a very small portion
of the dying population. In 1997, hospice provided services to an esti-
mated 495,000 patients.69
Moreover, hospice only serves its patients for a short period of
time. Large hospice providers report that they now have median
lengths of stay of less than two weeks.7" Christakis and Escarce found
the median survival time after enrollment for Medicare patients in
1990 was only 36 days.71 Almost 16% of patients died within 7 days
and over 28% died within 14 days of enrollment.72 Only 15% of Medi-
care patients enrolled in hospice were alive for six months or more.73
The authors concluded that the majority of hospice patients enter too
late to benefit from hospice and indicated that the optimal length of
stay for hospice patients is three months."
66. See BaRABRA MA.NAm & CHRISTOPHER PERRONE, HOSPICE CARE: AN INTRODUCTION
AND REVIEW OF THE EVIDENCE (National Hospice Org., 1994).
67. See 42 C.F.R. §418.3 (1998).
68. See 42 C.F.R. §418.302(f)(1) (1998).
69. See National Hospice Organization, Hospice Fact Sheet (updated Summer 1998)
<http://www.nho.org/facts.htm>; STAISTICAL ABSTRACT, supra note 13, at 134 (reporting
that hospice served 340,000 dying patients (about 15% of 2,294,000 deaths) in 1994).
70. Interview with Carolyn Cassin, Chief Operating Officer, VistaCare, in Washington,
D.C. (June 1998); Interview with David Rehm, Regional Vice President of Operations,
VistaCare, in Washington, D.C. (June 1998); Interview with Melanie Merriman, Consultant,
Touchstone Consulting, in Washington, D.C. (Aug. 1998).
71. See Nicholas A. Christakis & Jose J. Escarce, Survival of Medicare Patients after Enroll-
ment in Hospice Programs, 335 NEW ENG. J. MED. 172, 174 (1996).
72. See id.
73. See id.
74. See id.
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Increased utilization of hospice has been retarded by recent au-
dits conducted by the Department of Health and Human Services
(DHHS) Office of the Inspector General (OIG) under "Operation Re-
store Trust," which has alleged improprieties in hospices that enrolled
persons who live beyond six months.7" The first audit report, issued
in late 1996, stated that the hospice investigated had erred in admit-
ting 176 of the 364 patients who were either enrolled for more than
210 days or who had been discharged alive over a 27 month period.76
However, those 364 cases represented about 2% of all patients en-
rolled in the hospice during that period, and the hospice had an over-
all median length of stay of only 47 days.7 7
One important implication of the OIG's campaign is that the cur-
rent Medicare hospice benefit does not support a longer length of
stay for those dying of cancer and cannot be made to match the
course of most of those dying of congestive heart failure and other
more unpredictable diseases.78 In a recent analysis, the authors ap-
plied a number of current expert measures of disease severity of CHF
to persons enrolled in the SUPPORT study.79 Of the 1300 patients
with severe CHF who survived the first hospitalization, three-quarters
lived more than six months.8 0 Of the approximately 250 patients who
probably would have met criteria for hospice enrollment for severe
heart failure, three-quarters were still alive at six months.8 Thus, the
current enrollment criteria can serve to greatly limit hospice access
among a very sick population but will do so inequitably, since they are
unable to separate the "dying soon" from others with similar needs for
services.
According to a 1997 report by the Institute of Medicine (IOM):
[T] he current per diem of $94.17 for routine home care may
discourage the use of certain costly pain medications, even
when less expensive drugs fail; late-night nursing visits to
deal with medical or emotional crisis; the appropriate appli-
cation of high-technology equipment (e.g., infusion pumps);
75. See IMPROVING CARE AT THE END OF LIFE, supra note 8, at 169 n.l1.
76. See id.
77. See id.
78. See id.
79. See BRAD STUART ET AL., THE NATIONAL HOSPICE ORG., MEDICAL GUIDELINES FOR
DETERMINING PROGNOSIS IN SELECTED NON-CANCER DISEASES 8 (2d ed. 1996).
80. See id. at 2.
81. See Joanne Lynn et al., Effects of National Hospice Organization Guidelines on Hospice
Eligibility and Survival in Congestive Heart Failure, SGIM (abstract in press, 1998).
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and extensive counseling services for particularly distressed
patients and families.8 2
In sum, hospice can offer a unique and beneficial set of services
but only for a limited population for a limited length of time. There
is no question that hospice can be extremely valuable for individuals
with cancer and other highly predictable illnesses. However, to the
majority of people in the last phase of life, hospice is not available or
appropriate. The combination of the investigations by the OIG, the
public's reluctance to "give up" curative treatments and accept hos-
pice, and the limited prognoses eligible for hospice in light of the
presently restrictive interpretation of the Medicare hospice benefit,
make it clear that dying Americans need another alternative when fac-
ing the ends of their lives.
Another noteworthy model of care is the Program of All-inclusive
Care for the Elderly, or PACE. 3 PACE is a community-based delivery
and financing program that integrates acute and long-term care serv-
ices which go beyond the usual Medicare and Medicaid benefits.8 4
PACE serves nursing home certified frail elderly (55+) in hospitals,
physician offices, adult day clinic and home settings from enrollment
to death.85 PACE is a nationwide demonstration based on the On Lok
Senior Health Services begun in 1983 in San Francisco's Chinatown. 6
PACE programs were developed to test whether the On Lok program
could be generalized to other settings and nine sites were granted
Medicare and Medicaid waivers to establish PACE programs.8 7 Enroll-
ment is limited to frail elderly certified as eligible for nursing home
level care.88
Under PACE, comprehensive acute and long-term care services
are provided by a single organization through an interdisciplinary
team of providers s.8  Each site offers the same comprehensive array of
acute and long-term care services, including adult day care, nursing
home care, home care, prescription drugs, and rehabilitation.9" The
long-term care services are more extensive than those offered in the
82. See IMPROVING CARE AT THE END OF LIFE, supra note 8, at 170.
83. See Catherine Eng, Program of All-inclusive Care for the Elderly (PACE): An Innovative
Model of Integrated Geriatric Care and Financing, 45 J. AM. GERIATRICS Soc'y 223, 224 (1997).
84. See id.
85. See id.
86. See id.
87. See id.
88. See id.
89. See id. at 226.
90. See id. at 225.
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traditional Medicare HMOs. 1 PACE is financed through a monthly
capitation payment from Medicare and Medicaid.92
PACE sites have had difficulty in enrolling patients (often be-
cause eligible persons are reluctant to change physicians) and have
had difficulty in recruiting physician and other health professionals.9"
Additionally, the target group for PACE is small: nursing home certifi-
able persons.94 The typical PACE enrollee is 80 years old, female, with
an average of three limitations in activities of daily living and an aver-
age of eight medical conditions.9" While PACE appears to have set
the standard for excellent, integrated services for the very frail and
poor, even more than hospice, its scope of access seems likely to re-
main quite small for the foreseeable future despite having been made
a permanent part of Medicare in 1998.96
Another model worthy of discussion is the Social Health Mainte-
nance Organizations, or SHMOs, which extend the idea of a health
maintenance organization by including limited long-term care serv-
ices in their benefit package.97 The goal of the SHMO was to enroll
an elderly population with a wide range of disability and income
levels.98 This strategy allowed SHMOs to enroll moderate-income in-
dividuals as well as Medicaid eligible and nursing home certified
elderly.99
The program is voluntary and members pay a monthly premium
for services but can disenroll during any month of operation.1"'
Members receive all Medicare-covered acute, post acute, and ambula-
tory services, as well as some supplemental benefits (e.g., prescription
drugs, eyeglasses, hearing aids, and non-emergency transporta-
tion)."' Those who qualify for long-term care benefits can also re-
91. See id. at 230.
92. See id. at 224.
93. See id. at 226.
94. See id. at 224.
95. See MARLEEN L. CLARK ET AL., PACE FACT BOOK, 32, 44, 69 (On Lok, Inc., 2d ed.
1996).
96. See Legislative Summaries: Summary of Health Related Provisions of P.L. 105-33 Balanced
Budget Act, HEALTH LEGIS. & REG. WKLy., Feb. 4, 1998 available in 1998 WL 10395680.
97. See WALTER N. LEUTZ ET AL., CHANGING HEALTH CARE FOR AN AGING SOCIETY. PLAN-
NING FOR THE SOCIAL HEALTH MAINTENANCE ORGANIZATION (Lexington/Heath, 1985);
Charlene Harrington & RobertJ. Newcomer, Social Health Maintenance Organizations' Service
Use and Costs, 12 HEALTH CARE FIN. REV. 37, 37 (1991); Walter N. Leutz et al., Integrating
Acute and Long-term Care, 13 HEALTH ArFFAts 59 passim (1994).
98. See generally Harrington & Newcomer, supra note 97.
99. See Leutz, Integrating Acute and Long-term Care, supra note 97, at 62.
100. See Charlene Harrington et al., A Comparison of S/HMO Disenrollees and Continuing
Members, 30 INQUIRY 429, 430 (1993).
101. See Leutz, Integrating Acute and Long-term Care, supra note 97, at 59-60.
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ceive limited nursing home, home care services, homemaker,
personal care, and/or adult day care services, provided by the SHMO
or under contract to other providers.1"2
Evaluations of the SHMOs identified a number of problems. En-
rollment in SHMOs was slow, and evaluators found evidence of
favorable selection among enrollees.' 0 3 Although the SHMO enroll-
ment and service packages were designed to serve a cross-section of
functionally able and disabled elderly, the overwhelming majority of
enrollees did not have disabilities. 0 4 According to Manton et al., frail
elderly were not proportionately attracted to SHMOs, despite the pro-
vision of some long-term care services.105 In addition, in an attempt
to control costs, long-term care services were capped at $7,500 to
$9,600 per person per year.' 06 Thus, SHMOs did not cover extended-
stay nursing home care or long-term, intensive home care.
Moreover, almost haft of those disenrolling expressed dissatisfac-
tion with medical care (difficulty in getting appropriate tests and treat-
ments, lack of choice of physicians, lack of continuity of doctors, etc.)
and complaints about costs (e.g., premiums were too high, benefits
dropped).107 There also was great variation in service utilization
across plans and a reduction in service benefits over time.' 0 8 Further-
more, whether acute and long-term care services were actually "inte-
grated" remains an open question.' 09
The two principal models of integration of acute and long-term
care, the SHMOs and On Lok/PACE, demonstrate that a number of
issues still need to be addressed by policy makers and program plan-
ners. At one extreme, the SHMO attempts to enroll a broad mix of
individuals with and without disabilities and pool their resources to
cover the costs of intense care users. Wiener & Skaggs identify two
disadvantages to the SHMO approach: modest levels of long-term
care benefits and lack of the economies of scale necessary to develop
distinct services for disabled members. 110
102. See id. at 60.
103. See Kenneth G. Manton et al., A Method for Adjusting Capitation Payments to Managed
Care Plans Using Multivariate Patterns of Health and Functioning- The Experience of Social/Health
Maintenance Organizations, 32 MED. CARE 277, 295 (1994).
104. See id.
105. See id. at 295.
106. SeeEng, supra note 83, at 230.
107. See Harrington et al., supra note 100, at 433.
108. See id. at 433.
109. SeeJOSHUA M. WIENER &JASON SKAGGS, THE BROOKINGS INST., CURRENT APPROACHES
TO INTEGRATING AcuTE AND LONG-TERM CARE FINANCING AND SERVICES 38 (1995).
110. See id. at 39-40.
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At the other extreme, the On Lok/PACE program enrolled a
population with severe disabilities and provided comprehensive long-
term care services, including nursing home care.111 The advantage to
this approach is that the needs of this population are the only focus of
the program and caregivers from a wide range of disciplines makes it
more likely that the needs of the "whole" person were addressed. Nev-
ertheless, these were a small number of very high-cost users of care.
In addition, geriatric, interdisciplinary teams, the "heart" of the PACE
programs, are difficult to organize and run in the traditional, frag-
mented service delivery system.1 2 Kane points out that not only are
geriatricians "scarce," the egalitarianism of the team may make it hard
for many physicians to accept.1
Nevertheless, the SHMOs and the On Lok/PACE programs
demonstrate important features encouraging for a quality end-of-life
care program. However, a variety of other economic, social, and ethi-
cal issues within managed care systems could be impediments. Man-
aged care systems, like medical care systems more generally, have not
attended to the special needs of aging persons who live with chronic
diseases from which they are expected to die.114 Friedman and Kane
surveyed the medical directors of 64 HMOs with Medicare risk con-
tracts in 1991 (75% of all Medicare risk contracts) and found that
most programs did not have a geriatrician or generalist with addi-
tional geriatric training on staff" 5 in addition, they found a large
majority were not systematically assessing functional status or other
important social or health characteristics for the elderly and chroni-
cally ill. 1 16 This lack of attention is alarming since Medicare benefi-
ciaries have been enrolling in risk-contract and HMO managed care
plans since 1972.117 Approximately 171 risk contracts served 2.8 mil-
111. See Eng, supra note 83, at 223-24.
112. See WEINER & SKAGGS, supra note 109, at 2.
113. See Robert L. Kane et al., Qualitative Analysis of the Program of All-inclusive Care for the
Elderly (PACE), 32 GERONTOLOGIST 771, 780 (1992).
114. See Robert H. Binstock, Public Policies on Aging in the Twenty-First Century, 9 STANFORD
L. & POL'Y REV. 311, 317 (1998).
115. See Bruce Friedman & Robert L. Kane, HMO Medical Directors' Perceptions of Geriatric
Practice in Medicare HMOs, 41 J. AM. GERIATRIcs Soc'v 1144, 1146 (1993).
116. See id. at 1148.
117. See Friedman &.Kane, supra note 115, at 1144 ("While the federal government au-
thorized risk contracts with HMOs willing to provide services to Medicare beneficiaries as
far back as 1972, only two HMOs entered into such contracts...
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lion beneficiaries in 1995 and 10 large HMOs enrolled 44% of all
Medicare beneficiaries in 1995.118
Although enrollment by the elderly in managed care plans has
been slow and concentrated in a few states, beneficiary enrollment has
been expanding rapidly. 19 Another issue of concern for a managed
care plan has to do with adverse selection.120 Managed care organiza-
tions that are at full or partial financial risk for plan members may
perceive a program which offers integrated care for those nearing the
end of life to be financially risky. The special care required by those
growing increasingly sick over a lengthy period before they die could
be costly, especially if not well organized. The threat of adverse risk
selection has created incentives in most managed care plans against
investing in care for the terminally ill. 121 Medicare is expanding the
risk contracting options available to managed care plans to encourage
more plans to enroll greater numbers of beneficiaries. 122 New risk
contract initiatives include Medicare SELECT, which offers a network-
based supplemental (Medigap) insurance, risk plans offering point-of-
service options, 123 and expansion of the SHMO.
124
The Balanced Budget Amendments (BBA) of 1997125 mandated inno-
vation and variety in HMO contracting arrangements under Medi-
care. The new "Part C" of Medicare, called the Medicare+Choice
program, allows a wider range of providers to contract with the Health
Care Financing Administration (HCFA) .126 The following options are
outlined in the Medicare+Choice provision of the BBA but, as of this
118. See U.S. GENERAL Accr. OFF., MEDICARE HMOs: RAPID ENROLLMENT GROWTH CON-
CENTRATED IN SELECTED STATES 2 (1996) (GAO/HEHS-96-93) (Report to the Honorable
John F. Kerry, U.S. Senate) [hereinafter GAO REPORT].
119. See id.
120. Adverse selection can be defined as:
The market distortion that arises when subscribers have more knowledge about
their individual risks than insurers have or that insurers are allowed to have in
their premiums. The effect is that, when insurance purchase is voluntary, a dis-
proportionate number of high-risk subscribers will enroll.
Mark A. Hall, REFORMING PRIVATE HEALTH INSURANCE 97 (1994). See also Stanley B. Jones,
Why Not the Best for the Chronically 111? 2-3 (The George Washington University Health Insur-
ance Reform Project, 1996) (describing the phenomenon of adverse selection in managed
care as the avoidance of enrolling the most costly and needy beneficiaries in a health
plan).
121. See id. at 2.
122. See id. at 4.
123. Under a point of service health plan, members choose how to receive services when
the service is needed, with different cost-sharing levels associated with the choice. GAO
REPORT, supra note 118, at 4 n.8.
124. See id. at 4.
125. See P.L. 105-33, 111 Stat. 251 (1997).
126. See Binstock, supra note 114, at 317.
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writing, only the original fee-for-service Medicare plan and Medicare
HMOs are available.1 27
* ORIGINAL MEDICARE PLAN (FEE-FOR-SERVICE MEDICARE). This option
allows beneficiaries to select almost any doctor, hospital or other
health provider. Medicare makes its payment for health care serv-
ices, and the beneficiary pays deductibles and coinsurance and bal-
ance billing amounts and may choose to purchase supplemental
coverage.
* HEALTH MAINTENANCE ORGANIZATIONS (HMOs). Beneficiaries
must obtain services from a designated network of doctors, hospi-
tals and other health care providers who have agreed to provide
care to plan enrollees, usually with little or no out-of-pocket
payments.
* HMOs WITH POINT OF SERVICE (POS) OPTION. When combined
with a basic HMO package, the POS allows beneficiaries to selec-
tively go out of network to receive services with higher out-of-
pocket payments.
* PREFERRED PROVIDER ORGANIZATIONS (PPOs). Beneficiaries obtain
services from a network of providers that has been set up by the
health plan. Beneficiaries can choose to see someone out of net-
work but will pay higher out-of-pocket payments to do so.
* PROVIDER SPONSORED ORGANIZATIONS (PSOs). PSOs are formed by
a group of hospitals and doctors and directly take on financial risk
of providing comprehensive health care.
* MEDICAL SAVINGS ACCOUNTS (MSAs). Medicare pays the premium
for the MSA plan and makes a deposit into the Medicare MSA that
is established by the beneficiary. These funds pay for services
before the deductible is met and for other non-covered services.
There are no limits on what providers can charge above the
amount paid by the Medicare MSA plan.128
The new Medicare+Choice program, which allows a wider range
of providers to contract with the Health Care Financing Administra-
tion,"' while untried, opens the possibility that MediCaring teams
could contract directly with HCFA or through private physician
groups as yet another financing model.
127. See HEALTH CARE FIN. ADMIN., NATIONAL MEDICARE EDUCATION TASK FORCE FACT-
SHEET 3 (1998).
128. See id. at 3-4.
129. See Binstock, supra note 114, at 317.
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II. MkozCA, rv 3 °: AN ALTERNATIVE FOR A SPECIAL POPULATION
Chronically ill patients in the last phase of life might best be con-
sidered a "special population," distinguished by clinical severity (e.g.,
functional status or cardiac performance status) and their distinct
care needs. While some of these patients will have unpredictable
courses to death, most will have serious, established, long-term ill-
nesses such as heart failure, dementia, emphysema, and stroke. These
patients have traditionally been selected against in managed care mar-
keting and retention1 3 ' and their common needs are not now priori-
ties in routine medical care.'3 2
Reliable and effective care for the dying cannot be targeted just at
the "actively dying," as in the hospice paradigm, nor just on the ex-
tremely frail, long-term care population, as in the PACE program.
Rather, end-of-life care must include all people who are affected by
serious chronic illness which will cause death, but over a longer, less
predictable, period of time than is now provided. Indeed, the
problems of those nearing the end of life with an array of chronic
illnesses cannot be addressed by the Medicare hospice benefit as it is
now structured nor by the mere expansion of the PACE program.
Even managed care, which has great potential to serve this popula-
tion, has incentives to avoid high cost populations. Managed care or-
ganizations that are at full or partial financial risk for plan members
may perceive a program which offers integrated care for those near-
ing the end of life to be financially risky. 3 The special care required
by those growing increasingly sick over a lengthy period before they
die could be costly, especially if not well organized. The threat of ad-
verse risk selection has created incentives in most managed care plans
against investing in care for the terminally ill.'
34
We need to build a sustainable, accountable system of "usual"
care that appropriately serves most seriously ill patients and their fami-
lies, irrespective of health care delivery setting (e.g., home, nursing
home, hospital). Building upon the knowledge and successes of both
hospice and PACE, MediCaring will be an innovative program of com-
prehensive and coordinated health care which blends the best of pal-
liative care with the best of medical and disease management, tailored
130. The MediCaring projects are planned as a five to six-year series of sequential
demonstration programs culminating in a Medicare financed national demonstration
designed to reform Medicare.
131. SeeJones, supra note 120, at 2-3.
132. See id. at 3.
133. See id. at 4.
134. See id. at 2.
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to the needs of the seriously chronically ill. l"5 The program focuses
on heart and lung disease (i.e., CHF and COPD) patients nearing the
end of life (the last 2-3 years).1 "6 The MediCaingeligible population
will be identified using severity of illness threshold measures specific
to major chronic diseases rather than a prognosis definition (as is now
the case with hospice).137
MediCaring builds on the premise that good care of the dying calls
for interdisciplinary approaches to care (e.g., primary care physician,
advanced practice nurse, social worker, clergy, etc.), continuity and
coordination of care, integration of diverse services delivered in a vari-
ety of settings, excellent symptom management, maintenance of func-
tion, patient/family counseling and support, attention to spiritual and
personal growth issues, and a change in the orientation and culture of
providers to provide care shaped by the patient's values and personal
situation.1 38
MediCating would not be a duplication of the hospice or PACE
programs. 131 While comprehensive institutional and community-
based care, managed by interdisciplinary teams of health care profes-
sionals, marshalling existing resources within the community for so-
cial services, and care tailored to the individual's needs are hall-marks
of all three programs, MediCaring would serve populations not now
being served, would extend this care to hospital settings, and would
test a financing mechanism (incentives) and range of prices that
would allow a systematic program to be instituted in Medicare. 140 For
example, PACE membership turns on nursing home certification;
that is, only those people with complex medical needs, who require
intensive, ongoing care and with substantial functional disability are
eligible."' This is a very different population than that envisioned to
be served by MediCaing, which would focus on those individuals suf-
fering from advanced CHF or COPD (i.e., both younger and more
functionally able that those in PACE but also for whom there are no
end-of-life care options.) 142 Moreover, MediCating is primarily a pro-
135. See THE CENTER TO IMPROVE CARE OF THE DYING, GEORGE WASHINGTON UNIVERSITY
MEDICAL CENTER, MEDICARING PROGRAM EVALUATION PROJECTS: UPDATE ON PROGRAM DE-
VELOPMENT ACTrVTs 1 (visited Dec. 1998) <http://www.abcd-caring.com/MediCar-
ing.htm> [hereinafter MEDICARING PROGRAM UPDATE]; see also Skolnick, supra note 30, at
1511.
136. See MEDICARING PROGRAM UPDATE, supra note 135, at 1.
137. See id.
138. See id.
139. See id.
140. See id.
141. See Eng, supra note 83, at 223.
142. See MEDICARING PROGRAM UPDATE, supra note 135, at 1.
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gram financed by existing Medicare funds1 4 - generally targeted to-
ward traditional rescue care - and cannot go forward without a
restructuring of the payment structure. MediCaring is also very differ-
ent from hospice in that MediCating would use disease severity as the
main enrollment criterion and thus, would be able to enroll CHF,
COPD, and other diseases, which have inherently unpredictable sur-
vival times. 1 4 4
MEDICARING SERVICES. Except for hospice services for cancer,
there is little data as to how to characterize optimal end-of-life care
pathways. End-of-life care has mostly been a by-product of the domi-
nant health care system, arising with no particular attention to disease
at death and often with quite variable services: A MediCaring program
would prioritize services quite differently than conventional care: each
patient will have a constant primary care provider (e.g., advanced
practice nurse and/or physician), regardless of setting (e.g., hospital,
nursing home, hospice, home).145 Services would include, but not be
limited to: comprehensive care management coordination, home and
personal care, appropriate emergency medical care, access to 24-hour
"urgent" care advice nurse with authority to manage care over the tel-
ephone, medical equipment and supplies, personal care, rehabilita-
tion, environmental adaptations, and inpatient respite care. 146
In addition, creative combinations of life-prolonging and "sup-
portive care" services would be available (either at home or in an insti-
tutional setting) to replace traditional "rescue" care that may no
longer serve the patient or reflect responsible stewardship of re-
sources within the care system. 147 Unlike usual hospice practice, how-
ever, no treatment (e.g., intensive care, cardiopulmonary
resuscitation) will be barred, 148 and thus patients will not have to ex-
plicitly give up access to life-sustaining measures. 49 While services
could become as extensive as hospice, if needed, it is expected that
most MediCating patients will be less dependent, less symptomatic, and
less rapidly changing than the usual hospice (cancer) patient, so serv-
ices will generally be less intensive and vary over time. 150 MediCaring
would make it easy to get supportive care, which is now hard to get,
143. See id.
144. See id.
145. See Skolnick, supra note 30, at 1512.
146. See id.
147. See id. (quoting comments of Anne M. Wilkinson speaking before the Innovators in
End-of-Life Care National Conference in May 1998).
148. See id.
149. See id.
150. See id. at 1513.
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and would make it harder to get ventilators and/or surgery, which
now are easy.
Comprehensive care management coordination will also incorpo-
rate earlier and more open discussion'of advance care planning and
Do Not Resuscitate (DNR) orders for chronically ill patients in the last
phase of life, leading to more appropriate and patient-centered treat-
ments. Decision-making and management of the patient would rest
with the patient and families. Effectively, MediCaing creates a discern-
ibly different care program for the seriously chronically ill at the end
of life much in the same way that we have created systematic obstetri-
cal care as a distinct care program.
MEDICARING ELIGIBILITY. In contrast to hospice, MediCaring eligi-
bility criteria would be based on severity and utilization measures spe-
cific to major disease categories, with administratively practical and
culturally appropriate thresholds of disease.' 51 For example, people
would qualify when an illness becomes severe enough to shape much
of the person's life and is expected to be fatal. Defining the thresh-
olds requires more practical experience, but examples might be peo-
ple who have:
2 hospitalizations within the last year for CHF/COPD; COPD
with continuous oxygen (p02<55 at rest) or CHF with ejec-
tion fraction of <30%, and NYHA class III or IV function on a
usual day for CHF.'5 2
These guidelines will enable the MediCating population to be
much broader than that covered under the traditional hospice pro-
gram. In addition, the program will not bar access to any particular
treatment and therefore should not take on the "toxicity" of the hos-
pice label, which many people resist, in part, because it is perceived to
be such a harsh turning away from treatment and such a strong
marker for imminent death.' 53 Programs that examine a policy of re-
allocating resources from traditional hospital-based rescue care to im-
proved home and community supportive care that more appropriately
meet the needs of those facing "life-defining, eventually fatal illnesses"
would be of great value and would significantly improve quality.
MEDICARING FINANCING. MediCaring aims to provide improved
home and community-based palliative and supportive care without in-
151. See id.
152. See id.
153. See id. (quoting comments of Anne M. Wilkinson speaking before the Innovators
in End-of-Life Care National Conference in May 1998).
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creasing average Medicare costs. 15 4  The potential cost reductions
from MediCaring will arise mainly from the diminishing use of acute-
care interventions that can be prevented, either with aggressive pre-
emptive community-based care, by honoring the decisions regarding
treatment choices of patients and families, or by the effectiveness of
coordination and continuity.'55 Since the MediCaring program will
serve only "sicker" patients, payment levels to service providers must
end up being appropriately adjusted. The proposed demonstration
projects will have to include the development of risk-adjusted pay-
ments to assure that providers receive sufficient revenues to deliver
the comprehensive package of services needed by the average termi-
nally ill person. This is essential in order to encourage improved qual-
ity and to attract sufficient numbers of high-cost beneficiaries.
For example, as opposed to "conventional" disease management,
all MediCating patients would unambiguously have established diagno-
ses (which would ensure a low risk of "gaming" the larger Medicare
system) and the eligibility criteria could be set so as to accommodate
administrative considerations (e.g., the price and services can be set to
match the populations to be served). Schematically, in any one year,
the population expenditures in Medicare look like the following dia-
gram. (See Figure 3).
FIGURE 3
EXPENDITURES IN MEDICARE
Conventional Medicare-
Mostly healthy or
unpredictably ill
< all beneficiaries
11 Predictable high expenses
EXPENSES/YEAR with different care needs
154. See id.
155. See id. (quoting comments of Anne M. Wilkinson speaking before the Innovators in
End-of-Life Care National Conference in May 1998).
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If MediCating patients were "taken out" of the general insurance
pool, two very interesting things would happen. The MediCaring pop-
ulation can have a fair rate of capitation or other payments because
they have largely predictably high expenses while the non-MediCaring
population would become a more tractable insurance pool with un-
predictable risks of high costs. This kind of program, with tailored
services and special payment rates, would work for patients with ad-
vanced chronic illness for two reasons. First, the chronically ill popu-
lation has much less variance than the overall Medicare population
and therefore can be identified and then priced at a special rate. Sec-
ond, the non-chronically ill population has much less variation. High-
cost users in the general Medicare population are much more likely to
be unpredictable in any one year and, therefore, providers cannot
"game" the reimbursement system by selection bias. Providers would
then have to compete on value and quality, and not on favorable risk
selection. The unpredictable user of services does not generally pose
risks of very high costs to the system, and thus could be folded into a
general population risk pool that is more equitable for the Medicare
program.
MediCaring offers the opportunity to test the important question
of fair risk adjustment under Medicare. It is largely MediCating pa-
tients who, on the first of any year, can readily be predicted to have
high costs that year. It is all too easy now to bias recruitment and
retention so as to minimize an organization's exposure to these risks.
If, instead, care provider organizations have to compete on quality
and value, the adverse risk selection would theoretically decrease.
The participating provider organizations would be responsible for
measuring and reporting specific outcomes, including physical and
emotional symptoms, advance care planning, aggressive care near
death, and patient and family satisfaction. This is essential in setting
accountability for quality in the program.
Most financing schemes could support a MediCating program, ex-
cept traditional fee-for-service. Straightforward fee-for-service, with its
separate payments to physicians and hospitals for their services, virtu-
ally precludes sustained or widespread excellence in end-of-life care
(i.e., routinely establishing multidisciplinary teams, ensuring con-
tinuity of care, making promises between patients and providers, and
sustaining a care focus upon symptoms, function, and meaningful-
ness). The hospice model of financing (team capitation and physi-
cian fee-for-service), along with the risk-bearing capitation structure of
Medicare managed care or PACE, or the salaried budget of the De-
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partment of Veterans Affairs (DVA) offer the best opportunities for
successful MediCating payment and service delivery.
Each of these reimbursement modes could enable organizations
to plan and deliver comprehensive services to defined patient popula-
tions, to be accountable for quality and value, and to use centralized
resources and flexibility in choice and delivery of services within a
capitated or global budget. For example, hospice is financed mainly
by a daily capitation.156 The direct physician payment through Medi-
care Part B under the hospice benefit, as in traditional fee-for-service
medicine, makes hospice reimbursement a very interesting amalga-
mated payment mechanism.15 7 The payment to a team of providers at
risk for most patient care, while maintaining separate utilization of
physician services, could promote multidisciplinary team manage-
ment, control of care, and create the potential added role of a pri-
mary care physician as an independent patient/family advocate and
"whistle-blower" when needed. It also may make passage of a MediCar-
ing statute more politically feasible in the long run, since physicians
would have less reason to object to such a program because they
would still be "included" in the patient's care and patients would be
reassured by being able to remain with a long-standing physician. Sal-
aried systems, such as the DVA, offer the advantage of fewer reasons to
find the care provider in ethical conflicts of interest with very sick pa-
tients. While fee-for-service physicians might risk over-use of interven-
tions and managed care physicians might risk denying services,
salaried physicians have much less incentive in either direction.
Financing end-of-life care under a program like MediCaring would
free care systems to realize system efficiencies, such as utilizing poten-
tially lower cost palliative care services in a variety of lower cost set-
tings (e.g., hospital, nursing home or home) coordinated by lower
cost nurses or health professionals (e.g., nurses, nurse practitioners)
and to develop innovative programs with more flexibility in service
delivery arrangements by utilizing pooled Medicare, Medicaid, and
private wealth. In addition, extending a health plan's responsibility to
cover the full range of end-of-life care services would encourage plans
to control service delivery though more careful deliberation about
what types of acute and long-term care services would most benefit the
patient, family, and the care system.
156. See MANARD & PERRONE, supra note 66, at 14.
157. See id. at 14-15.
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III. FEDERAL INITIATIVES THAT COULD IMPACT END-OF-LIFE CARE
Recent trends and directives from the federal government, in ad-
dition to the changes inherent in the aforementioned Medi-
care+Choice program, may have a real impact on the plausibility of a
MediCating program implementation. The Advance Planning and
Compassionate Care Act of 1997, introduced by Senator Rockefeller
(D-WV) and Senator Collins (R-ME) and Representative Levin (D-
MI), requires the Secretary of Health and Human Services to conduct
demonstration projects to develop new and innovative approaches to
providing end-of-life care to Medicare beneficiaries who are seriously
ill or who suffer from a medical condition likely to be fatal. 58 If legis-
lation like this is passed, MediCating could be a candidate for this kind
of federally-mandated demonstration.
Another legislative directive that may affect a possible role for
MediCaring is the statement of the Bipartisan Medicare Commission to
be released in March 1999.159 The Commission may determine that
there is a need for increased funding for demonstrations so that inno-
vative programs can be tried and possibly implemented. There has
been a great deal of furor in recent months about the long-term feasi-
bility of the Medicare program' "°-Congress may well be looking for
ways to use monies in alternative and innovative fashions.
Finally, the assisted suicide debates that have been ubiquitous in
media articles, professional forums, and public domains have piqued
legislative concern around the end-of-life care debate.1 6 1 The Lethal
Drug Abuse Prevention Act of 1998, which was introduced but then
failed, evidenced an effort to put an end to the legalized practice of
assisted suicide but also illustrated Congressional interest in providing
158. See S. 1345 §7, 105'h Cong. (1997); H.R. 2999 §7, 1051h Cong. (1997).
159. Media Advisory, The National Bipartisan Commission on the Future of Medicare,
June 12, 1998 (on file with authors).
160. See Kevin P. Kane, We're in the Money... or Are We?, ST. Louis POST-DIsPATcH, Feb.
25, 1999, at B9 (discussing Congress' and President Clinton's proposed budget plans to
ensure Medicare solvency for future decades); Politics & Policy Medicare: Panel Airs Projec-
tions as Deadline Looms, Am. POLITICAL NETWORK, Feb. 23, 1999, at 3 (discussing Medicare
Commission's possible proposals and policy experts' predictions of impact on Medicare);
Difficult Work Heats Up, CONG. DAILY, available in 1999 WL 7532251 (discussing pressure on
Congress to address Medicare insolvency).
161. See Casting a Cold Eye on 'Death with Dignity' Oregon Studies Year One of a Benchmark
Law, U.S. NEws & WORLD Rvr., Mar. 1, 1999, at 56 (discussing impact of Oregon's contro-
versial physician assisted suicide law); Clarence Page, When the Right-to-Die Advocates Threaten
Our Right to Live, CHI. TRIB., Feb. 24, 1999, at 17 (discussing events ofjournalist Mike Wal-
lace's lecture at the University of Michigan on the videotaped assisted suicide airing on
CBS' 60 Minutes); Erin Hoover Barnett, Assisted Suicide Remains a Hot Issue in Legislature,
PORTLAND OREGONtAN, Feb. 7, 1999, at C08.
[VOL. 2:268
MEDICARING: QuALITY END-OF-LIFE CARE
appropriate comfort care for those in the last phase of life.' 6 2 A sys-
tem like MediCating might offer a viable alternative for Americans
seeking the ability to live as fully as possible with serious chronic ill-
ness, and thereby move the focus away from the question of assisted
suicide to an answer of improved access to services.
CONCLUSION
We have a vision of a care system that will serve the vast majority
of dying persons, in which the usual person coming to the end of
their life is comfortable, confident of the care they will receive, and
living a meaningful life in care systems that are proud of high value,
sustained care. The aim of MediCaring is to help providers deliver on
that vision by being able to promise dying patients the following:
* patients will be offered the best of medical treatment, aiming to
prevent exacerbations, improve function and survival, and ensure
comfort;
" patients will never have to endure overwhelming pain, shortness of
breath or other symptoms;
" care will be continuous, comprehensive and coordinated;
" the patient and family will be prepare for everything that is likely
to happen in the course of the illness;
* wishes of the patient will be sought and respected, and fulfilled
whenever possible; and
" as providers we will do all we can to see the patient and their family
will have the opportunity to make the best of every day.
There are intriguing and attractive attributes in a model of health
care that includes a recognition of impending death, that provides the
right services at the right time, and has a financing mechanism that
pays a fair price. MediCaring would establish the needed protocols,
standards for accountability, and an appropriate pathway for most dy-
ing individuals. It would create a risk-bearing entity (e.g., the mul-
tidisciplinary team) with responsibility and accountability for quality
as well as value, and it would provide a mechanism to eliminate the
intense pressures on the current system to fill gaps in the current sys-
tem, either by "stretching" hospice eligibility or overusing home
health care.
MediCating offers unique possibilities for efficiencies in service
delivery and efficacy in service composition to its clients. With its mul-
tidisciplinary approach, MediCaring can deliver on the promises of a
good dying, allowing for a better "fit" between client and family needs
162. See S. 2151, 105'h Cong. (1997).
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and services provided. Moreover, MediCaring offers health care prov-
iders an opportunity to develop the special expertise in palliative care,
case management, and supportive care services needed to appropri-
ately manage a seriously ill population. Under MediCaring, allied
health professionals, specialists, and supportive services can all be
brought together under one management structure to create con-
tinuity, quality standards and accountability systems. Thus, the organi-
zational resources needed (e.g., provider feed-back processes, data
reporting systems, integrated care delivery and financing, etc.) to en-
sure the systematic pre-planning of services, effective management of
care, continuity across service settings, and measurement of outcomes
for quality and accountability could easily be established.
Methods for comparing providers on the basis of quality, not just
price, could be implemented, thereby making measurement and im-
provement part of everyday practice. Consumers would benefit by be-
ing able to intelligently select a provider based on clear, objective
indicators of quality, pain in the last weeks of life, psychological sup-
port provided to family after the death, etc. There is now no
equivalent opportunity for accountability to be "built into" conven-
tional medical care.
Finally, controlling the costs of medical care and providing excel-
lent care at the end-of-life will require policymakers, politicians, physi-
cians, and elderly patients themselves to evaluate the costs and
benefits of high technology interventions. Demonstrations such as
MediCaring, which examine a policy of reallocating resources from
traditional hospital-based "rescue" care to improved home and com-
munity supportive care that more appropriately meets the needs of
those facing "life-defining, eventually fatal illnesses," will be of great
value. Thus, projects to learn how to implement a good care system
for dying Medicare patients are extremely important. The MediCaring
projects are planned as a five to six-year series of sequential demon-
stration programs culminating in a Medicare financed national dem-
onstration designed to reform Medicare. The evaluation components
of MediCating will specifically assess the cost-effectiveness of the pro-
gram, the clinical thresholds used to define "terminal" illnesses, the
desirability of the services to beneficiaries, and the extent to which
quality of care has been improved including changes in advance care
planning, aggressive care near death, and patient and family
satisfaction.
There is no question that the time is ripe for the implementation
of a MediCaringlike program and for the aforementioned promises to
become reality for all patients and families. The aging of the baby
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boomers paired with the recent drastic improvements in medical tech-
nology mean that all of us-whether for ourselves or for aging par-
ents-need to be able to rely on a health care system that can meet
the variable needs of the seriously ill, even if those needs span a
course of years. In the debate over physician-assisted suicide, people
talk about the right to a "choice" of having a provider assist in suicide.
This isn't a true "choice" unless there exists an option of a health care
system that can adequately care for dying people. MediCating or simi-
lar alternatives could provide that option. And, regardless of one's
position in the controversial physician-assisted suicide debate, we can
all agree that options are what we want when facing the ends of our
lives.
